Press Release
GE Healthcare and Lantheus Phase III Clinical Trial Finds [18F]flurpiridaz PET Radiotracer Could Improve Detection of Coronary Artery Disease
September 13, 2022
Read More at Our Investor SiteWe do it by making a difference in the lives of our patients. Stay current with the latest news, information and events at Lantheus. Please visit our investor site for a complete list of recent and archived press releases. Follow us on LinkedIn for social media updates.
For media resources, including images, logos, videos, and more, browse our media library.
Press Release
September 13, 2022
Read More at Our Investor SitePress Release
September 1, 2022
Read More at Our Investor SitePress Release
August 4, 2022
Read More at Our Investor Site